6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 12 Jul 2022
- Reporting date
- 12 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,818 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 976-1,000 of 1,000 matching filings.
Per page
25
Current page
40
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
RESULT OF GENERAL MEETING
- Filing date
- 06 Jul 2022
- Reporting date
- 06 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 06 Jul 2022
- Reporting date
- 06 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK DISCLOSE DISCONTINUED OPERATIONS FROM Q2 2022
- Filing date
- 05 Jul 2022
- Reporting date
- 05 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 05 Jul 2022
- Reporting date
- 05 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 05 Jul 2022
- Reporting date
- 05 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Jul 2022
- Reporting date
- 01 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK COMPLETES ACQUISITION OF SIERRA ONCOLOGY
- Filing date
- 01 Jul 2022
- Reporting date
- 01 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 28 Jun 2022
- Reporting date
- 28 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
11-K
File 001-15170
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE
- Filing date
- 28 Jun 2022
- Reporting date
- 31 Dec 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
11-K
File 001-15170
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE
- Filing date
- 28 Jun 2022
- Reporting date
- 31 Dec 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK FILES SHINGRIX 18+ AT RISK INDICATION IN JAPAN
- Filing date
- 28 Jun 2022
- Reporting date
- 28 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 27 Jun 2022
- Reporting date
- 27 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 24 Jun 2022
- Reporting date
- 24 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 16 Jun 2022
- Reporting date
- 16 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
POSITIVE PHASE III DATA FOR GSK'S RSV OA VACCINE
- Filing date
- 10 Jun 2022
- Reporting date
- 10 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 09 Jun 2022
- Reporting date
- 09 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 07 Jun 2022
- Reporting date
- 07 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
US FDA APPROVAL OF PRIORIX
- Filing date
- 06 Jun 2022
- Reporting date
- 06 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
6-K
- Filing date
- 01 Jun 2022
- Reporting date
- 01 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing